Jul 23, 2015 - THE [PIRBRIGHT INSTITUTE]
The present invention provides a live, attenuated [coronavirus] comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.
The [Pirbright Institute] is a publicly funded private company.
Our major stakeholders are:
International funding and disease control agencies, such as [OIE], [WHO], the [European Commission], [Bill and Melinda Gates Foundation]
Microsoft founder [Bill Gates] sat down recently with [CNN] Chief Medical Correspondent [Sanjay Gupta] in Davos, Switzerland
"the benefits are in terms of reducing sickness, reducing population growth..."
US5464621A: Canine [corona virus] [vaccine]
Application status is Expired - Fee Related
Das Posting wurde vom Benutzer editiert (23.01.2020 20:11).